Put Your (Frozen) Eggs in the Bank: Welcome to the Bioeconomy
By Victoria Turk,
Motherboard
| 02. 23. 2015
[Quotes CGS Fellow Lisa Ikemoto]
Untitled Document
Emerging reproductive technologies are helping address medical issues that affect fertility and give us more choice when it comes to family planning. But they also risk presenting our bodies from a new perspective: as a commodity to be banked, bought, and sold.
These social and political implications are the subject of a commentary in the Journal of Law and the Biosciences, by UC Davis bioethicist Lisa Ikemoto. She writes that “supply of the cells and bodies necessary for assisted reproductive technology use depends on market thinking and structural inequality.” In other words, the market depends on a discrepancy between rich and poor: Those who can afford to buy, and those who are in enough financial need that they will sell their eggs and sperm.
“The whole practice of egg donation, sperm donation, surrogacy, and I think in addition to that egg freezing not only for one’s own self but as a way of expanding egg banking for others’ use: All that relies on wealth inequality,” Ikemoto told me in a phone interview.
Her piece focuses on egg...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...